Prognostic potential of mid-treatment nodal response in oropharyngeal squamous cell carcinoma.

David J ByunMoses M TamAdam S JacobsonMark S PerskyTheresa T TranBabak GiviMark D DeLacureZujun LiLouis B HarrisonKenneth S Hu

Published in: Head & neck (2020)

Patients with low-risk oropharynx cancer with ND of ≥43% by treatment day 20 had significantly improved LRC. The prognostic benefit of ND may assist in identifying candidates for treatment de-escalation.

Keyphrases

squamous cell carcinoma
clinical trial
lymph node
lymph node metastasis
papillary thyroid
combination therapy
locally advanced
study protocol
rectal cancer
childhood cancer